Spark Therapeutics (ONCE) Misses Q1 EPS by 11c

Spark Therapeutics (NASDAQ: ONCE) reported Q1 EPS of ($0.95), $0.11 worse than the analyst estimate of ($0.84). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.48 million.

For earnings history and earnings-related data on Spark Therapeutics (ONCE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Reading (RDI) Tops Q2 EPS by 4c